Feb 21 (Reuters) - Healius Ltd HLS.AX :
* NOW EXPECTS UNDERLYING FY 2024 EBITDA OF A$359 MILLION -
A$369
MILLION
* VOLUME GROWTH SEEN IN Q1 OF FY 2024 HAS SOFTENED
* EXPECTS UNDERLYING EBITDA OF A$158 MILLION - A$161 MILLION
FOR
HY
* NON-CASH IMPAIRMENT CHARGE OF A$603 MILLION WILL BE MADE
TO
GOODWILL IN PATHOLOGY DIVISION IN 1H 2024 RESULTS
* RESPONDING TO SOFTENED VOLUME GROWTH WITH ACCELERATED PLAN
TO
RESHAPE BUSINESS AND MATCH COSTS TO CURRENT VOLUMES
Source text for Eikon: ID:nASX9D28y0
Further company coverage: HLS.AX
((Reuters.Briefs@thomsonreuters.com;))